Wells Fargo notes that Humana’s (HUM) lawsuit challenging Medicare Advantage RADV rule was successful on procedural grounds, as the Northern District Court of TX found that the Final Rule is procedurally invalid as it was not a “logical outgrowth” of the Proposed Rule. The issue had been back in greater focus following CMS announcement on significant expansion of audits. Wells points out that it is unclear whether it is truly a settled issue, but it should help to allay immediate concerns.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HUM:
- Humana initiated, Paycom upgraded: Wall Street’s top analyst calls
- Humana Inc.: Hold Rating Amid Uncertain Medium-Term Outlook and Execution Risks
- Humana initiated with an In Line at Evercore ISI
- Private Markets: Databricks valued at over $100B in latest fundraising
- UnitedHealth price target raised to $395 from $325 at Morgan Stanley